Mounjaro Atlanta

Medications offered

As listed on the provider’s own site. Whether a product is FDA-approved or compounded is the single most important distinction here — we explain why.

• Compounded tirzepatideCompounded · not FDA-approved

What they publish

Mounjaro Atlanta publishes 1 of 12 standard terms. Fields marked “not publicly disclosed” were not stated on the pages we captured, and we have not filled those gaps with assumptions. Compare disclosure across providers

Membership / programme fee

$295 for a first 6 weeks or $395 for a first 8 weeks, published as new-patient start-up dosage pricing (as published)

Medication cost

Not publicly disclosed on the pages we captured.

Introductory offer

New patients only, at start-up dosages

Insurance

Not publicly disclosed on the pages we captured.

HSA / FSA

Not publicly disclosed on the pages we captured.

Consultation process

Not publicly disclosed on the pages we captured.

Eligibility

Not publicly disclosed on the pages we captured.

Lab work

Not publicly disclosed on the pages we captured.

Pharmacy fulfilment

Not publicly disclosed on the pages we captured.

Shipping

Not publicly disclosed on the pages we captured.

Support services

Not publicly disclosed on the pages we captured.

Cancellation

Not publicly disclosed on the pages we captured.

Refunds

Not publicly disclosed on the pages we captured.

What stands out

• The domain is the name of an FDA-approved Eli Lilly product, but the footnote states what is supplied is patient-specific compounded tirzepatide. Those are different things, and a reader who does not read footnotes could easily conclude otherwise.
• 'Patient-specific' is the 503A framing — compounded against an individual prescription rather than batch-produced.
• The published prices are explicitly for new patients at start-up dosages, so the maintenance-dose cost is a separate question.

Questions to ask before you pay

These are things we could not settle from published pages, or that we think are easy to misread. Get answers in writing.

• Confirm in writing whether you are receiving branded Mounjaro or a compounded product. The domain name is not the answer.
• Establish the price at your maintenance dose, since these figures are start-up only.
• Ask which pharmacy compounds it and whether it is 503A or 503B.

Frequently asked